CHRISTA MCCOLL: Open Payments
NPI 1821701012 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 22 payments from 13 companies in 2025. Trend: 2023 $2,159 · 2024 $959 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $201 |
| Novo Nordisk Inc | 3 | $74 |
| Amgen Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Fresenius USA Marketing, Inc. | 2 | $32 |
| Genentech USA, Inc. | 1 | $30 |
| Calliditas Therapeutics US Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Apellis Pharmaceuticals, Inc. | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
Products named: IBSRELA, XPHOZAH 30 MG, Wegovy, KRYSTEXXA, Kerendia, VELPHORO, Gazyva, TARPEYO.
Industry payments across GA — which companies pay providers there.
